Spyre Therapeutics board member Peter Harwin resigns; annual meeting approves ESPP amendment
Filed May 29, 2026 · Period ending May 27, 2026 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade SYRE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 30, 2026 3:05 AM